Frederick Locke, MD

Dr. Locke is Vice Chair in the Department of Blood and Marrow Transplant and Cellular Immunotherapy Program Co-Leader at Moffitt Cancer Center.

Articles by Frederick Locke, MD

ZUMA-7 Trial: How CAR-T Is Redefining LBCL Treatment

Melissa BadamoAggressive B-Cell Lymphoma | May 30, 2025

Dr. Frederick Locke discussed the ZUMA-7 trial of axi-cel versus standard of care for patients with relapsed/refractory LBCL.

Frederick Locke on Axi-cel and ZUMA-7

Frederick Locke, MDAggressive B-Cell Lymphoma | November 14, 2022

Frederick Locke, MD, from Moffitt Cancer Center, shares findings from the ZUMA-7 trial, which evaluated the chimeric antigen ...